Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 2a (5-HT2a) receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine D2 receptor | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | Starlite/ChEMBL | References |
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 2c (5-HT2c) receptor | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0167 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0377 | 0.5143 | 0.6141 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0314 | 0.3598 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0167 | 0 | 0.5 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0314 | 0.3598 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0314 | 0.3598 | 0.5 |
Onchocerca volvulus | 0.0509 | 0.8374 | 0.5 | |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.0377 | 0.5143 | 1 |
Brugia malayi | Pax transcription factor protein 2 | 0.0509 | 0.8374 | 0.6652 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0509 | 0.8374 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0167 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0377 | 0.5143 | 0.6141 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0314 | 0.3598 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0314 | 0.3598 | 0.5 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0314 | 0.3598 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 3.2 nM | Ability to displace [3H]-prazosin (0.25 nM) from whole brain of rat alpha-1 adrenergic receptor | ChEMBL. | 12519065 |
Ki (binding) | = 3.2 nM | Ability to displace [3H]-prazosin (0.25 nM) from whole brain of rat alpha-1 adrenergic receptor | ChEMBL. | 12519065 |
Ki (binding) | = 4.2 nM | Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor | ChEMBL. | 12519065 |
Ki (binding) | = 4.2 nM | Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor | ChEMBL. | 12519065 |
Ki (binding) | = 35 nM | Ability to displace [3H]-5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor | ChEMBL. | 12519065 |
Ki (binding) | = 35 nM | Ability to displace [3H]-5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor | ChEMBL. | 12519065 |
Ki (binding) | = 55 nM | Displacement of [3H]-ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors | ChEMBL. | 12519065 |
Ki (binding) | = 55 nM | Displacement of [3H]-ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors | ChEMBL. | 12519065 |
Ki (binding) | = 91 nM | Displacement of [3H]-spiperone (0.5 nM) from rat corpus striatum dopamine D2 receptor | ChEMBL. | 12519065 |
Ki (binding) | = 91 nM | Displacement of [3H]-spiperone (0.5 nM) from rat corpus striatum dopamine D2 receptor | ChEMBL. | 12519065 |
Ki (binding) | = 120 nM | Displacement of [3H]-mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells | ChEMBL. | 12519065 |
Ki (binding) | = 120 nM | Displacement of [3H]-mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells | ChEMBL. | 12519065 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.